Atheronova Inc (AHROQ) Financial Statements (2024 and earlier)

Company Profile

Business Address 2301 DUPONT DRIVE, SUITE 525
IRVINE, CA 92612
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2014
MRQ
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 266,2102,744,046
Cash and cash equivalents 266,2102,744,046
Other current assets 22,438
Prepaid expense and other current assets17,622
Total current assets: 288,6482,761,668
Noncurrent Assets
Property, plant and equipment 7,4058,514
Deposits noncurrent assets 12,77723,777
Total noncurrent assets: 20,18232,291
TOTAL ASSETS: 308,8302,793,959
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 811,404603,629
Other undisclosed accounts payable and accrued liabilities 811,404603,629
Debt 390,123 
Other undisclosed current liabilities 76,46237,016
Total current liabilities: 1,277,989640,645
Noncurrent Liabilities
Long-term debt and lease obligation 363,133360,803
Long-term debt, excluding current maturities 363,133360,803
Other undisclosed noncurrent liabilities 1,170,712 
Total noncurrent liabilities: 1,533,845360,803
Total liabilities: 2,811,8341,001,448
Equity
Equity, attributable to parent, including: (2,503,004)1,792,511
Common stock 4,1473,711
Additional paid in capital 19,522,64316,003,872
Accumulated deficit (2,503,004)(14,215,072)
Other undisclosed equity, attributable to parent (19,526,790) 
Total equity: (2,503,004)1,792,511
TOTAL LIABILITIES AND EQUITY: 308,8302,793,959

Income Statement (P&L) (USD)

9/30/2014
TTM
12/31/2013
12/31/2012
Operating expenses (4,845,141)(3,637,986)
Operating loss: (4,845,141)(3,637,986)
Nonoperating income (expense) (599,207)5,142,620
Investment income, nonoperating  2,640,497
Debt instrument, convertible, beneficial conversion feature  1,498,333
Other nonoperating income 2,4571,003,790
Interest and debt expense (601,664)(871,431)
Other undisclosed loss from continuing operations before equity method investments, income taxes (1,767,345)(3,267,399)
Loss from continuing operations before income taxes: (7,813,357)(2,634,196)
Income tax expense (1,365)(1,365)
Loss from continuing operations: (7,814,722)(2,635,561)
Loss before gain (loss) on sale of properties: (7,814,722)(2,635,561)
Net loss available to common stockholders, diluted: (7,814,722)(2,635,561)

Comprehensive Income (USD)

9/30/2014
TTM
12/31/2013
12/31/2012
Net loss: (7,814,722)(2,635,561)
Comprehensive loss, net of tax, attributable to parent: (7,814,722)(2,635,561)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: